Quantcast

Latest Exagen Diagnostics Inc. Stories

2010-10-12 08:00:00

ALBUQUERQUE, N.M., Oct. 12 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the purchase of Cypress Bioscience, Inc.'s diagnostic business, located in San Diego, Calif. Under the terms of the agreement, Exagen will purchase the diagnostic business in its entirety, including all testing services, intellectual property rights and equipment. Exagen has offered employment to all Cypress...

2010-07-08 08:00:00

ALBUQUERQUE, N.M., July 8 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading organization of board-certified pathologists that serves patients, pathologists and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine. The CAP...

2010-02-16 08:00:00

ALBUQUERQUE, N.M., Feb. 16 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced an exclusive sales and marketing agreement with EndoChoice, Inc. to promote its diagnostic services to gastroenterologists throughout the United States. Under the agreement, EndoChoice's experienced, gastroenterology-focused sales force will introduce Exagen's proprietary gene expression tests for the...

2009-12-01 08:00:00

ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the appointment of Scott Glenn as chairman of the company's board of directors and chief executive officer. Prior to joining Exagen, Glenn was managing partner of Windamere Venture Partners and founder of a number of successful biomedical companies including Prometheus Laboratories, Santarus, Dexcom, Somaxon...

2009-05-28 08:00:00

Company signs partnership agreement with Clinical Reference Laboratory ALBUQUERQUE, N.M., May 28 /PRNewswire/ -- Exagen Diagnostics, Inc. today announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Exagen will present the tests at Digestive Disease Week 2009 in Chicago, May 30 - June 4, booth #2429. The eXaIBStest identifies patients with IBS, while the eXaIBD test identifies...

2009-02-17 08:49:00

ALBUQUERQUE, N.M., Feb. 17 /PRNewswire/ -- Exagen Diagnostics, Inc., which provides proprietary molecular diagnostics testing services, genomic probes for research and analytic specific reagents to clinical laboratories and academic institutions, today announced that John Alsobrook, Ph.D., has been named vice president and chief operating officer. In his new role, Alsobrook oversees Exagen's day-to-day operations, company alliances and genomic marker discovery and development programs. He...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'